OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CROWN.PS55

Crown Asia Chemicals Corp

Commodity ChemicalsVerified

Crown Asia Chemicals Corp maintains a strong liquidity position, with a current ratio of 5.6, indicating that it holds significantly more current assets than current liabilities. The company's liquidity_fpt score of 0.85 suggests a robust ability to meet short-term obligations, supported by PHP 405.2 million in cash and equivalents. The low debt-to-equity ratio of 0.01 further reinforces the company's conservative capital structure, with minimal reliance on long-term debt. In terms of profitability, the company's return on equity (ROE) of 3.36% and return on assets (ROA) of 2.75% are below the industry median for Commodity Chemicals, which typically sees ROE and ROA in the 5-7% and 3-5% ranges, respectively. This suggests that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue breakdowns in the input data limits the ability to assess the performance of individual product lines or geographic regions. Looking ahead, the company's revenue is projected to grow by 4.2% in the current fiscal year and 3.8% in the next fiscal year, based on the outlook data. This growth is modest compared to the industry average of 6-8% for Commodity Chemicals, suggesting that the company may be facing competitive pressures or market saturation. The capital expenditure of PHP 21.1 million in the latest period indicates a low level of investment in new capacity or technology, which may constrain long-term growth. The risk assessment for Crown Asia Chemicals Corp indicates a low probability of dilution and no immediate liquidity concerns. The company's low debt load and strong cash reserves reduce the likelihood of equity dilution through secondary offerings or convertible debt. However, the absence of disclosed dilution sources in the input data means that the risk of future dilution remains uncertain. Recent filings and transcripts do not indicate any material events or strategic shifts that would significantly impact the company's operations or financial performance. The company appears to be operating in a stable environment, with no disclosed regulatory or legal challenges in the latest financial data.

30-day price · CROWN.PS-0.03 (-1.8%)
Low$1.63High$1.74Close$1.65As of15 May, 00:00 UTC
Profile
CompanyCrown Asia Chemicals Corp
TickerCROWN.PS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Crown Asia Chemicals Corp is a chemical manufacturing company that produces and distributes commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. Crown Asia Chemicals Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Crown Asia Chemicals Corp maintains a strong liquidity position, with a current ratio of 5.6, indicating that it holds significantly more current assets than current liabilities. The company's liquidity_fpt score of 0.85 suggests a robust ability to meet short-term obligations, supported by PHP 405.2 million in cash and equivalents. The low debt-to-equity ratio of 0.01 further reinforces the company's conservative capital structure, with minimal reliance on long-term debt. In terms of profitability, the company's return on equity (ROE) of 3.36% and return on assets (ROA) of 2.75% are below the industry median for Commodity Chemicals, which typically sees ROE and ROA in the 5-7% and 3-5% ranges, respectively. This suggests that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue breakdowns in the input data limits the ability to assess the performance of individual product lines or geographic regions. Looking ahead, the company's revenue is projected to grow by 4.2% in the current fiscal year and 3.8% in the next fiscal year, based on the outlook data. This growth is modest compared to the industry average of 6-8% for Commodity Chemicals, suggesting that the company may be facing competitive pressures or market saturation. The capital expenditure of PHP 21.1 million in the latest period indicates a low level of investment in new capacity or technology, which may constrain long-term growth. The risk assessment for Crown Asia Chemicals Corp indicates a low probability of dilution and no immediate liquidity concerns. The company's low debt load and strong cash reserves reduce the likelihood of equity dilution through secondary offerings or convertible debt. However, the absence of disclosed dilution sources in the input data means that the risk of future dilution remains uncertain. Recent filings and transcripts do not indicate any material events or strategic shifts that would significantly impact the company's operations or financial performance. The company appears to be operating in a stable environment, with no disclosed regulatory or legal challenges in the latest financial data.
Key takeaways
  • Crown Asia Chemicals Corp has a strong liquidity position with a current ratio of 5.6 and PHP 405.2 million in cash and equivalents.
  • The company's ROE and ROA are below the industry median, indicating underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • Revenue growth is projected at 4.2% for the current fiscal year and 3.8% for the next, below the industry average.
  • The company has a low risk of dilution and no immediate liquidity concerns, but lacks disclosed dilution sources.
  • No material events or strategic shifts have been reported in recent filings or transcripts.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyPHP
Revenue$426.6M
Gross profit$145.0M
Operating income$89.6M
Net income$70.0M
R&D
SG&A
D&A
SBC
Operating cash flow$49.5M
CapEx-$21.1M
Free cash flow$63.0M
Total assets$2.55B
Total liabilities$464.7M
Total equity$2.08B
Cash & equivalents$405.2M
Long-term debt$15.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.74B$288.5M$224.3M$224.5M
FY-3$1.76B$301.0M$228.9M$173.2M
FY-2$1.51B$319.7M$247.8M$164.7M
FY-1$1.49B$241.1M$192.3M$115.3M
FY0$1.16B$170.8M$151.6M$97.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.00B$1.59B$108.6M
FY-3$2.08B$1.76B$255.0M
FY-2$2.49B$2.01B$374.2M
FY-1$2.48B$2.15B$367.7M
FY0$2.72B$2.36B$410.7M
PeriodOCFCapExFCFSBC
FY-4-$33.4M-$29.9M$224.5M
FY-3$250.7M-$34.2M$173.2M
FY-2$297.2M-$68.5M$164.7M
FY-1$155.9M-$60.1M$115.3M
FY0$287.4M-$39.2M$97.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$426.6M$89.6M$70.0M$63.0M
FQ-6$395.2M$65.7M$54.7M-$10.8M
FQ-5$390.8M$70.4M$46.9M$7.1M
FQ-4$279.0M$15.3M$20.7M$56.1M
FQ-3$300.6M$59.0M$45.2M$55.3M
FQ-2$265.1M$41.5M$32.1M-$19.4M
FQ-1$323.0M$60.6M$44.8M$55.2M
FQ0$270.9M$9.7M$29.4M$5.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$2.55B$2.08B$405.2M
FQ-6$2.55B$2.08B$402.2M
FQ-5$2.55B$2.12B$347.6M
FQ-4$2.48B$2.15B$367.7M
FQ-3$2.53B$2.20B$406.9M
FQ-2$2.50B$2.17B$408.3M
FQ-1$2.54B$2.21B$402.8M
FQ0$2.72B$2.36B$410.7M
PeriodOCFCapExFCFSBC
FQ-7$49.5M-$21.1M$63.0M
FQ-6$118.4M-$38.2M-$10.8M
FQ-5$114.3M-$90.5M$7.1M
FQ-4$155.9M-$60.1M$56.1M
FQ-3$40.3M-$2.1M$55.3M
FQ-2$101.0M-$4.8M-$19.4M
FQ-1$97.8M-$5.5M$55.2M
FQ0$287.4M-$39.2M$5.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.08B
Net cash$389.8M
Current ratio5.6
Debt/Equity0.0
ROA2.8%
ROE3.4%
Cash conversion71.0%
CapEx/Revenue-4.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricCROWN.PSActivity
Op margin21.0%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin16.4%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin34.0%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-4.9%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity1.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 01:58 UTC#14a0ea01
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 17:05 UTCJob: e55f1eb2